Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Myasthenia Gravis, MuSK”

11 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 11 of 11 results

Testing effectiveness (Phase 2)Looking for participantsNCT06414954
What this trial is testing

Safety and Efficacy of 3 Dose Levels of NMD670 in Adult Patients With Myasthenia Gravis

Who this might be right for
Myasthenia GravisMyasthenia Gravis, MuSK
NMD Pharma A/S 84
Early research (Phase 1)Study completedNCT05451212
What this trial is testing

Open-label Study to Evaluate the Safety of Various Dosing Regimens of MuSK-CAART for MuSK Myasthenia Gravis

Who this might be right for
MuSK Myasthenia Gravis
Cabaletta Bio 7
Large-scale testing (Phase 3)Looking for participantsNCT07039916
What this trial is testing

Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis

Who this might be right for
Generalized Myasthenia Gravis
Immunovant Sciences GmbH 231
Testing effectiveness (Phase 2)Looking for participantsNCT06106672
What this trial is testing

Evaluate the Safety, Tolerability, Pharmacodynamics and Efficacy of CNP-106 in Subjects With Myasthenia Gravis

Who this might be right for
Myasthenia GravisGeneralized MyastheniaAChR Myasthenia Gravis+1 more
COUR Pharmaceutical Development Company, Inc. 54
Not applicableLooking for participantsNCT06617741
What this trial is testing

Myasthenia Gravis Foundation of America Global MG Patient Registry

Who this might be right for
Myasthaenia GravisMyastheniaMyasthenia Gravis Associated with Thymoma+10 more
Myasthenia Gravis Foundation of America 3,800
Not applicableLooking for participantsNCT06259071
What this trial is testing

MuSK Myasthenia 1000 Study

Who this might be right for
Myasthenia GravisMuSK MGMuSK Myasthenia Gravis
Myasthenia Gravis Rare Disease Network 1,000
Large-scale testing (Phase 3)Study completedNCT03304054
What this trial is testing

Study to Evaluate Amifampridine Phosphate in Patients With MuSK-MG

Who this might be right for
Myasthenia Gravis, Generalized
Catalyst Pharmaceuticals, Inc. 93
Testing effectiveness (Phase 2)Looking for participantsNCT06359041
What this trial is testing

RESET-MG: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Generalized Myasthenia Gravis

Who this might be right for
Generalized Myasthenia Gravis (gMG)
Cabaletta Bio 12
Large-scale testing (Phase 3)Looking for participantsNCT06463587
What this trial is testing

Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)

Who this might be right for
Generalized Myasthenia Gravis
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany 264
Not applicableStudy completedNCT05219097
What this trial is testing

The Specificity, Sensitivity and Clinical Correlation of CBA, RIPA and ELISA in Detecting AChR and MuSK IgG of Myasthenia Gravis

Who this might be right for
Detection Autoantibody of Myasthenia Gravis
Tianjin Medical University General Hospital 2,663
Large-scale testing (Phase 3)Ended earlyNCT03579966
What this trial is testing

Long Term Safety Study of Amifampridine Phosphate in MuSK-MG (Muscle Specific Tyrosine Kinase Myasthenia Gravis)

Who this might be right for
Myasthenia Gravis, MuSKAChR Myasthenia Gravis
Catalyst Pharmaceuticals, Inc. 63